A5000832921- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Mechanical Circulatory Support Devices
- Cardiac Imaging and Diagnostics
- Peptidase Inhibition and Analysis
- Kawasaki Disease and Coronary Complications
- Cardiac pacing and defibrillation studies
- Cardiac Structural Anomalies and Repair
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiomyopathy and Myosin Studies
- Neonatal Health and Biochemistry
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Eosinophilic Disorders and Syndromes
- Hemoglobinopathies and Related Disorders
- Elasticity and Material Modeling
- Dialysis and Renal Disease Management
- Diabetes Treatment and Management
- Viral Infections and Immunology Research
- Folate and B Vitamins Research
- Vitamin K Research Studies
Azienda Ospedaliero-Universitaria Careggi
2023-2025
University of Florence
2023-2025
Associazione Nazionale Medici Cardiologi Ospedalieri
2017
Heart failure with preserved ejection fraction (HFpEF) results from a complex interplay of age, genetic, cardiac remodeling, and concomitant comorbidities including hypertension, obesity, diabetes, chronic kidney disease (CKD). Renal is an important comorbidity HFpEF, as well major pathophysiological mechanism for those patients at risk developing HFpEF. (HF) CKD are intertwined conditions sharing common pathways; the so-called “kidney tamponade”, explained by increase in intracapsular...
Cardiac resynchronization therapy (CRT) is an established treatment in selected patients suffering from heart failure with reduced ejection fraction (HFrEF). It has been proposed that myocardial fibrosis and inflammation could influence CRT "response" outcome. Our study investigated the long-term prognostic significance of cardiac biomarkers HFrEF indication for CRT.Consecutive referred implantation were retrospectively evaluated. The soluble suppression tumorigenicity 2 (sST2), galectin-3...